BB Biotech AG (FRA:BBZA) Cyclically Adjusted Book per Share: €41.74 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:BBZA BB Biotech AG FRA:BBZA
15 GF Score
Price €33.35
! 4 Warning Signs
View Full Analysis

What is BB Biotech AG Cyclically Adjusted Book per Share?

BB Biotech AG FRA:BBZA 15 Cyclically Adjusted Book per Share is €41.74 as of Mar. 2026. GuruFocus rates FRA:BBZA with a GF Score™ of 15/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BB Biotech AG's adjusted book value per share for the three months ended in Mar. 2026 was €52.462. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €41.74 for the trailing ten years ended in Mar. 2026.

During the past 12 months, BB Biotech AG's average Cyclically Adjusted Book Growth Rate was -1.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -5.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -4.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of BB Biotech AG was -0.60% per year. The lowest was -5.50% per year. And the median was -2.20% per year.

As of today (2026-07-26), BB Biotech AG's current stock price is €33.35. BB Biotech AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €41.74. BB Biotech AG's Cyclically Adjusted PB Ratio of today is 0.80.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BB Biotech AG was 1.36. The lowest was 0.46. And the median was 0.87.


BB Biotech AG  (FRA:BBZA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BB Biotech AG's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=33.35/41.74
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BB Biotech AG was 1.36. The lowest was 0.46. And the median was 0.87.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BB Biotech AG Cyclically Adjusted Book per Share Related Terms


BB Biotech AG Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for BB Biotech AG's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG Cyclically Adjusted Book per Share Chart

BB Biotech AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.87 67.26 64.54 59.15 41.41

BB Biotech AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.64 60.39 51.98 41.41 41.74

FRA:BBZA vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, BB Biotech AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Cyclically Adjusted PB Ratio falls into.


FRA:BBZA
15GF Score
BB Biotech AG FRA:BBZA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BB Biotech AG's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=52.462/108.0600*108.0600
=52.462

Current CPI (Mar. 2026) = 108.0600.

BB Biotech AG Quarterly Data

Book Value per Share CPI Adj_Book
201506 68.801 100.464 74.003
201509 57.035 99.785 61.765
201512 65.895 99.386 71.646
201603 42.928 99.475 46.633
201606 43.651 100.088 47.128
201609 50.051 99.604 54.300
201612 50.424 99.380 54.828
201703 54.383 100.040 58.743
201706 55.243 100.285 59.526
201712 54.685 100.213 58.967
201812 46.141 100.906 49.412
201903 0.000 101.571 0.000
201906 0.000 102.044 0.000
201909 0.000 101.396 0.000
201912 56.097 101.063 59.981
202003 41.664 101.048 44.555
202006 61.101 100.743 65.539
202009 54.122 100.585 58.144
202012 64.928 100.241 69.993
202103 63.899 100.800 68.501
202106 66.790 101.352 71.210
202109 63.857 101.533 67.962
202112 57.062 101.776 60.586
202203 48.928 103.205 51.230
202206 44.678 104.783 46.075
202209 51.488 104.835 53.072
202212 49.628 104.666 51.237
202303 41.879 106.245 42.595
202306 42.287 106.576 42.876
202309 42.048 106.570 42.636
202312 44.916 106.461 45.591
202403 46.702 107.355 47.009
202406 45.235 107.991 45.264
202409 43.237 107.468 43.475
202412 44.718 107.128 45.107
202503 37.219 107.722 37.336
202506 35.961 108.075 35.956
202509 44.771 107.710 44.916
202512 53.997 107.200 54.430
202603 52.462 108.060 52.462

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €41.74 mean?
BB Biotech AG (FRA:BBZA) has a Cyclically Adjusted Book per Share of €41.74 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BB Biotech AG and its competitors.
Is BB Biotech AG's Cyclically Adjusted Book per Share too high?
BB Biotech AG's current Cyclically Adjusted Book per Share is €41.74. Overall, BB Biotech AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Cyclically Adjusted Book per Share compare to VRTX and REGN?
BB Biotech AG's Cyclically Adjusted Book per Share of €41.74 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current Cyclically Adjusted Book per Share is €41.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (FRA:BBZA) has a current Cyclically Adjusted Book per Share of €41.74. The current Cyclically Adjusted Book per Share is €41.74. BB Biotech AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For BB Biotech AG (FRA:BBZA), the current Cyclically Adjusted Book per Share is €41.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Other Exchanges BION:Switzerland
Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
15GF Score

Get the complete analysis for FRA:BBZA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€33.35
Price